FDA Inspection 1273078 — DB Biologics, LLC

DB Biologics, LLC — FEI 3006761306

The FDA completed an inspection of DB Biologics, LLC on Jun 18, 2025 in Harrisburg, PA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jun 18, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Harrisburg, PA (United States)

Citations

IDCFRDescription
33321 CFR 640.64(e)Prevention of contamination

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.